Similar articles for PMID: 21784898

Year	Number of Results
2007	1
2008	3
2009	4
2011	9
2012	12
2013	4
2014	8
2015	12
2016	13
2017	11
2018	14
2019	15
2020	14
2021	2

1

Rituximab-induced depletion of anti-PLA2R autoantibodies predicts response in membranous nephropathy.

Beck LH Jr, Fervenza FC, Beck DM, Bonegio RG, Malik FA, Erickson SB, Cosio FG, Cattran DC, Salant DJ. Beck LH Jr, et al. J Am Soc Nephrol. 2011 Aug;22(8):1543-50. doi: 10.1681/ASN.2010111125. Epub 2011 Jul 22. J Am Soc Nephrol. 2011. PMID: 21784898 Free PMC article.

2

Anti-Phospholipase A2 Receptor Antibody Titer Predicts Post-Rituximab Outcome of Membranous Nephropathy.

Ruggenenti P, Debiec H, Ruggiero B, Chianca A, Pellé T, Gaspari F, Suardi F, Gagliardini E, Orisio S, Benigni A, Ronco P, Remuzzi G. Ruggenenti P, et al. J Am Soc Nephrol. 2015 Oct;26(10):2545-58. doi: 10.1681/ASN.2014070640. Epub 2015 Mar 24. J Am Soc Nephrol. 2015. PMID: 25804280 Free PMC article.

3

Circulating anti-PLA2R autoantibodies to monitor immunological activity in membranous nephropathy.

Cravedi P, Ruggenenti P, Remuzzi G. Cravedi P, et al. J Am Soc Nephrol. 2011 Aug;22(8):1400-2. doi: 10.1681/ASN.2011060610. Epub 2011 Jul 22. J Am Soc Nephrol. 2011. PMID: 21784892 Free article. No abstract available.

4

Clinical usefulness of autoantibodies to M-type phospholipase A2 receptor (PLA2R) for monitoring disease activity in idiopathic membranous nephropathy (IMN).

Radice A, Trezzi B, Maggiore U, Pregnolato F, Stellato T, Napodano P, Rolla D, Pesce G, D'Amico M, Santoro D, Londrino F, Ravera F, Ortisi G, Sinico RA. Radice A, et al. Autoimmun Rev. 2016 Feb;15(2):146-54. doi: 10.1016/j.autrev.2015.10.004. Epub 2015 Oct 23. Autoimmun Rev. 2016. PMID: 26527329 Review.

5

Successful Treatment of Patients With Refractory PLA₂R-Associated Membranous Nephropathy With Obinutuzumab: A Report of 3 Cases.

Klomjit N, Fervenza FC, Zand L. Klomjit N, et al. Am J Kidney Dis. 2020 Dec;76(6):883-888. doi: 10.1053/j.ajkd.2020.02.444. Epub 2020 Apr 18. Am J Kidney Dis. 2020. PMID: 32311405

6

Circulating anti-phospholipase A2 receptor antibodies as a diagnostic and prognostic marker in Greek patients with idiopathic membranous nephropathy - a retrospective cohort study.

Provatopoulou S, Kalavrizioti D, Stangou M, Kouri MN, Kalliakmani P, Papasotiriou M, Papachristou E, Goumenos DS, Papagianni A. Provatopoulou S, et al. Rom J Intern Med. 2019 Jun 1;57(2):141-150. doi: 10.2478/rjim-2018-0044. Rom J Intern Med. 2019. PMID: 30864406 Free article.

7

Anti-phospholipase A₂ receptor antibodies correlate with clinical status in idiopathic membranous nephropathy.

Hofstra JM, Beck LH Jr, Beck DM, Wetzels JF, Salant DJ. Hofstra JM, et al. Clin J Am Soc Nephrol. 2011 Jun;6(6):1286-91. doi: 10.2215/CJN.07210810. Epub 2011 Apr 7. Clin J Am Soc Nephrol. 2011. PMID: 21474589 Free PMC article.

8

Anti-phospholipase A2 Receptor Antibody and Immunosuppression in Membranous Nephropathy: More Evidence for Pathogenicity of Anti-phospholipase A2 Receptor Autoantibodies.

Brenchley PE. Brenchley PE. J Am Soc Nephrol. 2015 Oct;26(10):2308-11. doi: 10.1681/ASN.2015020181. Epub 2015 Mar 24. J Am Soc Nephrol. 2015. PMID: 25804283 Free PMC article. No abstract available.

9

M-type phospholipase A2 receptor autoantibodies and renal function in patients with primary membranous nephropathy.

Hoxha E, Harendza S, Pinnschmidt H, Panzer U, Stahl RA. Hoxha E, et al. Clin J Am Soc Nephrol. 2014 Nov 7;9(11):1883-90. doi: 10.2215/CJN.03850414. Epub 2014 Sep 29. Clin J Am Soc Nephrol. 2014. PMID: 25267554 Free PMC article.

10

Autoantibodies against phospholipase A2 receptor in Korean patients with membranous nephropathy.

Oh YJ, Yang SH, Kim DK, Kang SW, Kim YS. Oh YJ, et al. PLoS One. 2013 Apr 26;8(4):e62151. doi: 10.1371/journal.pone.0062151. Print 2013. PLoS One. 2013. PMID: 23637987 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed